You just read:

Neuronix Reports Positive Results From Its Multi-Center Alzheimer's Study At The Clinical Trials In Alzheimer's Disease (CTAD) Conference

News provided by

Neuronix Ltd.

04 Jan, 2017, 09:00 GMT